Clinical Trial Update: Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a monoclonal antibody therapy in relapsed lymphoma after chemotherapy and autologous stem cell transplantation (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: University of Nebraska | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED